Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara A Burtness

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
Molecular Cancer Therapeutics|April 20, 2026
Quantification of Antibody-Drug Conjugate Targets in Head and Neck Squamous Cell CarcinomaMengni He, Ioannis P Trontzas, Katherine M Bates, et al.
Nature Communications|April 20, 2021
STING enhances cell death through regulation of reactive oxygen species and DNA damageThomas J Hayman, Marta Baro, Tyler MacNeil, et al.
Molecular Cancer Therapeutics|August 11, 2016
EGFR and RB1 as Dual Biomarkers in HPV-Negative Head and Neck CancerTim N Beck, Rachel Georgopoulos, Elena I Shagisultanova, et al.
American Journal of Clinical Oncology|March 18, 2016
Induction Therapy for Locally Advanced, Resectable Esophagogastric Cancer: A Phase I Trial of Vandetanib (ZD6474), Paclitaxel, Carboplatin, 5-Fluorouracil, and Radiotherapy Followed by ResectionPatrick M Boland, Joshua E Meyer, Adam C Berger, et al.
Scientific Reports|September 21, 2018
Pretreatment Identification of Head and Neck Cancer Nodal Metastasis and Extranodal Extension Using Deep Learning Neural NetworksBenjamin H Kann, Sanjay Aneja, Gokoulakrichenane V Loganadane, et al.
Oncology|December 2, 2005
Five-year update of an expanded phase II study of dose-dense and -intense doxorubicin, paclitaxel and cyclophosphamide (ATC) in high-risk breast cancerMaysa M Abu-Khalaf, Stephen Windsor, Keita Ebisu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 21, 2010
Detection of tumor epidermal growth factor receptor pathway dependence by serum mass spectrometry in cancer patientsChristine H Chung, Erin H Seeley, Heinrich Roder, et al.
Head & Neck|February 14, 2019
Unique mutation patterns in anaplastic thyroid cancer identified by comprehensive genomic profilingSaad A Khan, Bo Ci, Yang Xie, et al.
Head & Neck|February 4, 2020
Adjuvant external beam radiotherapy for surgically resected, nonmetastatic anaplastic thyroid cancerNadia A Saeed, Jacqueline R Kelly, Hari A Deshpande, et al.
Molecular Cancer Therapeutics|January 23, 2026
NN-01-195, a novel conjugate of HSP90 and AURKA inhibitors, effectively targets solid tumorsTheodore T Nguyen, Nitesh K Nandwana, Yellamelli V V Srikanth, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Molecular Cancer Therapeutics|April 20, 2026
Quantification of Antibody-Drug Conjugate Targets in Head and Neck Squamous Cell CarcinomaMengni He, Ioannis P Trontzas, Katherine M Bates, et al.
Nature Communications|April 20, 2021
STING enhances cell death through regulation of reactive oxygen species and DNA damageThomas J Hayman, Marta Baro, Tyler MacNeil, et al.
Molecular Cancer Therapeutics|August 11, 2016
EGFR and RB1 as Dual Biomarkers in HPV-Negative Head and Neck CancerTim N Beck, Rachel Georgopoulos, Elena I Shagisultanova, et al.
American Journal of Clinical Oncology|March 18, 2016
Induction Therapy for Locally Advanced, Resectable Esophagogastric Cancer: A Phase I Trial of Vandetanib (ZD6474), Paclitaxel, Carboplatin, 5-Fluorouracil, and Radiotherapy Followed by ResectionPatrick M Boland, Joshua E Meyer, Adam C Berger, et al.
Scientific Reports|September 21, 2018
Pretreatment Identification of Head and Neck Cancer Nodal Metastasis and Extranodal Extension Using Deep Learning Neural NetworksBenjamin H Kann, Sanjay Aneja, Gokoulakrichenane V Loganadane, et al.
Oncology|December 2, 2005
Five-year update of an expanded phase II study of dose-dense and -intense doxorubicin, paclitaxel and cyclophosphamide (ATC) in high-risk breast cancerMaysa M Abu-Khalaf, Stephen Windsor, Keita Ebisu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 21, 2010
Detection of tumor epidermal growth factor receptor pathway dependence by serum mass spectrometry in cancer patientsChristine H Chung, Erin H Seeley, Heinrich Roder, et al.
Head & Neck|February 14, 2019
Unique mutation patterns in anaplastic thyroid cancer identified by comprehensive genomic profilingSaad A Khan, Bo Ci, Yang Xie, et al.
Head & Neck|February 4, 2020
Adjuvant external beam radiotherapy for surgically resected, nonmetastatic anaplastic thyroid cancerNadia A Saeed, Jacqueline R Kelly, Hari A Deshpande, et al.
Molecular Cancer Therapeutics|January 23, 2026
NN-01-195, a novel conjugate of HSP90 and AURKA inhibitors, effectively targets solid tumorsTheodore T Nguyen, Nitesh K Nandwana, Yellamelli V V Srikanth, et al.
Pageof 8